Making long‐acting treatment work: Tracing connections with extended‐release buprenorphine depot through time

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sandra Gendera, Kari Lancaster, Tim Rhodes, Carla Treloar
Format: Artículo Open Access
Veröffentlicht: Wiley 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867020255621021696
author Sandra Gendera
Kari Lancaster
Tim Rhodes
Carla Treloar
author_facet Sandra Gendera
Kari Lancaster
Tim Rhodes
Carla Treloar
Sandra Gendera
Kari Lancaster
Tim Rhodes
Carla Treloar
collection Wiley Open Access
contents Making long‐acting treatment work: Tracing connections with extended‐release buprenorphine depot through time Sandra Gendera Kari Lancaster Tim Rhodes Carla Treloar Drug and Alcohol Review AbstractIntroductionHow people connect with opioid agonist treatment is an ongoing concern. Extended‐release buprenorphine depot (BUP‐XR) has been designed with ‘retention’ in mind. It is important to consider what makes a difference to clients in helping them to stay connected to treatment over time.MethodsWe report findings from the third wave of in‐depth interviews with participants (n = 26) in the Community Long‐Acting Buprenorphine (CoLAB) study, tracing accounts of connection, disconnection and reconnection with BUP‐XR since initiation into treatment.ResultsChanging situations in treatment delivery and in people's lives created conditions of possibility for connection and disconnection to treatment. Clients used BUP‐XR in different ways. Personalisation of dosing regimens and stretching out of time between doses was common, creating a sense of stability for some. For others, this flexibility potentiated fragility in treatment connection. Disconnection from BUP‐XR was common, but frequently this was not the ultimate outcome. Treatment connections were shaped by fluctuating life circumstances, with re‐connections imagined, attempted and sometimes realised.Discussion and conclusionsClients' accounts reveal the complexities of how ‘long‐acting’ treatments are made to work over time. Connecting with treatment in the long‐term is a process, contingent on social relations, fluctuating life conditions and systems of care. Rather than treating connection and disconnection as opposites, we suggest seeing these as entangled and fluid elements of an ongoing process. What is needed is an adaptive and emergent conceptualisation of what ‘retention’ in treatment can mean, reflective of how people connect with their treatment and make it work, in practice. 10.1111/dar.14021 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1111/dar.14021
format Artículo Open Access
id wiley_oa_10_1111_dar_14021
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Making long‐acting treatment work: Tracing connections with extended‐release buprenorphine depot through time
Sandra Gendera
Kari Lancaster
Tim Rhodes
Carla Treloar
Drug and Alcohol Review
Making long‐acting treatment work: Tracing connections with extended‐release buprenorphine depot through time Sandra Gendera Kari Lancaster Tim Rhodes Carla Treloar Drug and Alcohol Review AbstractIntroductionHow people connect with opioid agonist treatment is an ongoing concern. Extended‐release buprenorphine depot (BUP‐XR) has been designed with ‘retention’ in mind. It is important to consider what makes a difference to clients in helping them to stay connected to treatment over time.MethodsWe report findings from the third wave of in‐depth interviews with participants (n = 26) in the Community Long‐Acting Buprenorphine (CoLAB) study, tracing accounts of connection, disconnection and reconnection with BUP‐XR since initiation into treatment.ResultsChanging situations in treatment delivery and in people's lives created conditions of possibility for connection and disconnection to treatment. Clients used BUP‐XR in different ways. Personalisation of dosing regimens and stretching out of time between doses was common, creating a sense of stability for some. For others, this flexibility potentiated fragility in treatment connection. Disconnection from BUP‐XR was common, but frequently this was not the ultimate outcome. Treatment connections were shaped by fluctuating life circumstances, with re‐connections imagined, attempted and sometimes realised.Discussion and conclusionsClients' accounts reveal the complexities of how ‘long‐acting’ treatments are made to work over time. Connecting with treatment in the long‐term is a process, contingent on social relations, fluctuating life conditions and systems of care. Rather than treating connection and disconnection as opposites, we suggest seeing these as entangled and fluid elements of an ongoing process. What is needed is an adaptive and emergent conceptualisation of what ‘retention’ in treatment can mean, reflective of how people connect with their treatment and make it work, in practice. 10.1111/dar.14021 http://creativecommons.org/licenses/by/4.0/
title Making long‐acting treatment work: Tracing connections with extended‐release buprenorphine depot through time
topic Drug and Alcohol Review
url https://onlinelibrary.wiley.com/doi/10.1111/dar.14021